Valproic acid (VPA): Difference between revisions
Jump to navigation
Jump to search
imported>Xenbase No edit summary |
imported>Xenbase No edit summary |
||
| Line 15: | Line 15: | ||
==References== | ==References== | ||
*[http://www.xenbase.org/literature/article.do?method=display&articleId=55100 Rao and LaBonne 2018] | *[http://www.xenbase.org/literature/article.do?method=display&articleId=55100 Rao and LaBonne 2018] | ||
*[https://pubchem.ncbi.nlm.nih.gov/compound/ | *[https://pubchem.ncbi.nlm.nih.gov/compound/3121 NCBI PubChem CID:3121] | ||
> 84 Xenbase articles contain a reference to Valproic acid according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | > 84 Xenbase articles contain a reference to Valproic acid according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | ||
Latest revision as of 06:17, 25 October 2019
Description
"Valproic Acid is a synthetic derivative of propylpentanoic acid with antiepileptic properties and potential antineoplastic and antiangiogenesis activities. In epilepsy, valproic acid appears to act by increasing the concentration of gamma-aminobutyric acid (GABA) in the brain. This agent's antitumor and antiangiogenesis activities may be related to the inhibition of histone deacetylases and nitric oxide synthase, which results in the inhibition of nitric oxide synthesis. (NCI04)" Source: NCIt
Alternative names
- 2-Propylpentanoic acid
- 99-66-1
- Dipropylacetic acid
- 2-Propylvaleric acid
Usage Notes
References
> 84 Xenbase articles contain a reference to Valproic acid according to textpresso